SAI Group

    An integrated platform combining domestic accessibility with global regulatory expansion

    Revat Laboratories Private Limited

    Revat Laboratories forms the SAI Group's core domestic formulations platform. Incorporated in 1988 and operating from Ongole, Andhra Pradesh.

    Incorporated in 1988
    Large-scale oral solid dosage manufacturing
    Tablets, capsules, and liquid orals production
    Strengthened SAI's branded generics presence
    High-volume manufacturing base
    Cost-efficient production capabilities
    Serves institutional and retail markets

    Noumed Pharmaceuticals PTY Limited

    Noumed Pharmaceuticals marks the SAI Group's transformation into a truly global pharmaceutical platform. Headquartered in Australia with a presence in New Zealand.

    Headquarters in Australia with New Zealand presence
    Hundreds of approved regulated market dossiers
    Established pharmacy supply partnerships
    OTC and prescription product portfolio
    Direct participation in developed healthcare systems
    Manufacturing facility in Adelaide
    Integrated international platform

    SP Analytics Private Limited

    SP Analytics serves as the SAI Group's dedicated research and development arm, focused on formulation development, scale-up, and regulatory dossier preparation.

    End-to-end CDMO capabilities
    Formulation development and process optimization
    Regulatory dossier preparation
    Differentiated and complex formulations
    Global filings support
    Faster time-to-market enablement
    Scientific innovation and manufacturing integration

    The SAI Group reinforces an integrated model combining domestic accessibility with global regulatory expansion. By combining diverse capabilities across formulations, manufacturing, regulatory expertise, and research development, the Group supports its commitment to reliable and affordable medicines for institutional, retail, and international markets worldwide.